These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms. Au CH; Wa A; Ho DN; Chan TL; Ma ES Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102 [TBL] [Abstract][Full Text] [Related]
3. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia. Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608 [TBL] [Abstract][Full Text] [Related]
7. Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms. Kim B; Lee H; Jang J; Kim SJ; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR PLoS One; 2019; 14(3):e0212228. PubMed ID: 30840646 [TBL] [Abstract][Full Text] [Related]
8. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients. Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978 [TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing. Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340 [TBL] [Abstract][Full Text] [Related]
10. Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies. Papuc SM; Erbescu A; Cisleanu D; Ozunu D; Enache C; Dumitru I; Lupoaia Andrus E; Gaman M; Popov VM; Dobre M; Stanca O; Angelescu S; Berbec N; Colita A; Vladareanu AM; Bumbea H; Arghir A Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070898 [TBL] [Abstract][Full Text] [Related]
11. A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients. Prieto-Conde MI; Corchete LA; García-Álvarez M; Jiménez C; Medina A; Balanzategui A; Hernández-Ruano M; Maldonado R; Sarasquete ME; Alcoceba M; Puig N; González-Calle V; García-Sanz R; Gutiérrez NC; González-Díaz M; Chillón MC J Mol Diagn; 2020 Jan; 22(1):60-71. PubMed ID: 31605801 [TBL] [Abstract][Full Text] [Related]
12. Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia. Yang JJ; Park TS; Wan TS Methods Mol Biol; 2017; 1541():223-245. PubMed ID: 27910027 [TBL] [Abstract][Full Text] [Related]
13. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing. Kohlmann A; Bacher U; Schnittger S; Haferlach T Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312 [TBL] [Abstract][Full Text] [Related]
15. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies. Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing. Arindrarto W; Borràs DM; de Groen RAL; van den Berg RR; Locher IJ; van Diessen SAME; van der Holst R; van der Meijden ED; Honders MW; de Leeuw RH; Verlaat W; Jedema I; Kroes WGM; Knijnenburg J; van Wezel T; Vermaat JSP; Valk PJM; Janssen B; de Knijff P; van Bergen CAM; van den Akker EB; Hoen PAC'; Kiełbasa SM; Laros JFJ; Griffioen M; Veelken H Leukemia; 2021 Jan; 35(1):47-61. PubMed ID: 32127641 [TBL] [Abstract][Full Text] [Related]
18. How I investigate acute myeloid leukemia. Narayanan D; Weinberg OK Int J Lab Hematol; 2020 Feb; 42(1):3-15. PubMed ID: 31820579 [TBL] [Abstract][Full Text] [Related]
19. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing. Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155 [TBL] [Abstract][Full Text] [Related]
20. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]